AIMLogo.jpg
Hemispherx Biopharma Announces Financial Results for the Nine Months Ended September 30, 2014
10 nov. 2014 08h30 HE | AIM ImmunoTech Inc.
PHILADELPHIA, Nov. 10, 2014 (GLOBE NEWSWIRE) -- Hemispherx Biopharma (NYSE:HEB) announced its financial results for the three and nine months ended September 30, 2014. The net loss (including non-cash...
TVWorldwide.com
Ebola and the Best Practices in Treatment
04 nov. 2014 07h32 HE | TVWorldwide.com
Washington, D.C., Nov. 4, 2014 (GLOBE NEWSWIRE) -- In response to the recent Ebola outbreak and the importance that Vascular Access devices and procedures play in clinician treatment of patients with...
AIMLogo.jpg
Hemispherx Biopharma and United States Army Medical Research Institute of Infectious Diseases (USAMRIID) Collaborate on Alferon(R) and Ampligen(R) Against the Ebola Virus
03 nov. 2014 08h30 HE | AIM ImmunoTech Inc.
PHILADELPHIA, Nov. 3, 2014 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE MKT:HEB) (the "Company" or "Hemispherx"), has been informed by USAMRIID scientists that they have in-vitro data...
AIMLogo.jpg
Hemispherx Biopharma Reports New Evidence -- Based Potential of Ampligen(R) Against Ebola Virus Disease (EVD)
30 oct. 2014 08h30 HE | AIM ImmunoTech Inc.
PHILADELPHIA, Oct. 30, 2014 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE MKT:HEB) (the "Company" or "Hemispherx"), reported today a new peer reviewed publication entitled, "The Quest for...
New Ebola Guidelines Might Not Have Stopped NYC Tour, States Association of American Physicians and Surgeons (AAPS)
29 oct. 2014 11h03 HE | Association of American Physicians and Surgeons
TUCSON, Ariz., Oct. 29, 2014 (GLOBE NEWSWIRE) -- After a doctor returning from West Africa was admitted to Bellevue Hospital in New York City with Ebola, the CDC issued updated guidance for monitoring...
AIMLogo.jpg
Hemispherx Announces Strategic Relationship With Squire Patton Boggs, Washington, DC as Governmental Counsel in Fight Against Ebola
20 oct. 2014 12h00 HE | AIM ImmunoTech Inc.
PHILADELPHIA, Oct. 20, 2014 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE MKT:HEB) (the "Company" or "Hemispherx"), has retained Squire Patton Boggs (SPB) to serve as its global government...
PositiveID's Firefly
PositiveID's Firefly Dx System Featured on Hannity on Fox News
20 oct. 2014 08h30 HE | PositiveID Corporation
DELRAY BEACH, Fla., Oct. 20, 2014 (GLOBE NEWSWIRE) -- PositiveID Corporation ("PositiveID" or "Company") (OTCQB:PSID), a developer of biological detection and diagnostics solutions, today announced...
U.S. Ebola Response Not Up to African Standards, States Association of American Physicians and Surgeons (AAPS)
17 oct. 2014 13h59 HE | Association of American Physicians and Surgeons
TUCSON, Ariz., Oct. 17, 2014 (GLOBE NEWSWIRE) -- After the Oct 16 hearings before the House Energy and Commerce Subcommittee on Oversight and Investigations, the Association of American Physicians and...
Ebola Crisis Fund Receives Support From Pierre and Pam Omidyar
17 oct. 2014 10h45 HE | Geneva Global, Inc.
WAYNE, Pa., Oct. 17, 2014 (GLOBE NEWSWIRE) -- Capital for Good announced that it has received a $250,000 grant from Pierre & Pam Omidyar for the Ebola Crisis Fund. Established in mid-August, the Ebola...
PositiveID Corporati
PositiveID Corporation and ENSCO Awarded Contract for U.S. Department of Homeland Security SenseNet Program
10 oct. 2014 08h00 HE | PositiveID Corporation
DELRAY BEACH, Fla., Oct. 10, 2014 (GLOBE NEWSWIRE) -- PositiveID Corporation ("PositiveID") (OTCQB:PSID), a developer of biological detection and diagnostics solutions, today announced that it, in...